Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-18

Clinical Trial Update: Efficiency of Botulinum Toxin type-a in the Management of the Myofascial Pain [NA]

View source ↗

Summary

This completed clinical trial assessed the effectiveness of Botulinum toxin type A for myofascial pain associated with temporomandibular joint dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Hacettepe University | Conditions: Myofascial Pain - Dysfunction Syndrome of TMJ | NA | Status: COMPLETED